EUVIMEDEUVIMED entdecken
Fallbericht

Type 1 von Willebrand Disease in a Pediatric Patient Caused by a Novel Heterozygous Deletion of Exons 1 to 6 of the von Willebrand Factor Gene: A Case Report

Ivana Lapić, Margareta Radić Antolic, Dunja Rogić, Sara Dejanović Bekić, Désirée Coen Herak iD, Ernest Bilić, Renata Zadro

Laboratory Medicine · 2023

DOI: 10.1093/labmed/lmac138 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Laboratory Medicine, 2023. Verfasst von Ivana Lapić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia. Hauptthemen laut MEDLINE: von Willebrand Disease, Type 1, von Willebrand Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 6-year-old boy was referred to a hematologist due to excessive mucocutaneous bleeding. Diagnostic assessment for von Willebrand disease (VWD) was indicated and included both coagulation and genetic testing. Laboratory testing revealed proportionally decreased von Willebrand factor (VWF) glycoprotein Ib-binding activity (23.6%) compared to VWF antigen (24.7%), similarly decreased VWF collagen-binding activity (24.2%), and normally distributed VWF multimers, with decreased intensity of all fractions. Diagnosis of type 1 VWD was established. Genetic analysis by means of next-generation sequencing (NGS) of VWF and coagulation factor VIII genes did not identify any causative mutations. Additionally, multiplex ligation-dependent probe amplification (MLPA) of VWF gene exons revealed a heterozygous deletion of exons 1 to 6, which is reported in type 1 VWD for the first time. Application of MLPA was crucial for revealing the genetic basis of type 1 VWD in this case, which would have remained undetected if only NGS was used.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand Disease, Type 1von Willebrand DiseasesMaleHumansChildvon Willebrand FactorHemorrhageExons

Stichwörter der Autor:innen

bleedingcoagulation testingmultiplex ligation-dependent probe amplificationnext-generation sequencingvon Willebrand diseasevon Willebrand factor

Substanzen

von Willebrand Factor

Autor:innen und Institutionen

  • Department of Laboratory Diagnostics, University Hospital Center Zagreb, Zagreb, Croatia.
  • Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
  • Referral Center for Pediatrics Hematology and Oncology, Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia.
  • Medical Biochemistry Laboratory, St Catherine Specialty Hospital, Zagreb, Croatia.

ORCID-Profile: Désirée Coen Herak

Zitieren

APA

Lapić, I., Radić Antolic, M., Rogić, D., Dejanović Bekić, S., Coen Herak, D., Bilić, E., & Zadro, R. (2023). Type 1 von Willebrand Disease in a Pediatric Patient Caused by a Novel Heterozygous Deletion of Exons 1 to 6 of the von Willebrand Factor Gene: A Case Report. Laboratory Medicine. https://doi.org/10.1093/labmed/lmac138

Vancouver

Lapić I, Radić Antolic M, Rogić D, Dejanović Bekić S, Coen Herak D, Bilić E, et al. Type 1 von Willebrand Disease in a Pediatric Patient Caused by a Novel Heterozygous Deletion of Exons 1 to 6 of the von Willebrand Factor Gene: A Case Report. Laboratory Medicine. 2023. doi:10.1093/labmed/lmac138

BibTeX
@article{Lapi2023,
  author = {Lapić, Ivana and Radić Antolic, Margareta and Rogić, Dunja and Dejanović Bekić, Sara and Coen Herak, Désirée and Bilić, Ernest and Zadro, Renata},
  title = {Type 1 von Willebrand Disease in a Pediatric Patient Caused by a Novel Heterozygous Deletion of Exons 1 to 6 of the von Willebrand Factor Gene: A Case Report},
  journal = {Laboratory Medicine},
  year = {2023},
  doi = {10.1093/labmed/lmac138}
}
Kostenlos starten →